News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Pfizer Inc.'s Crizotinib Wipes Out Rare Lymphoma in Two Test Cases
February 24, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Pfizer Inc.’s experimental drug to treat a type of lung cancer appeared to wipe out a rare form of lymphoma in two severely ill patients in test cases reported by doctors.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Postmarket research
Pfizer
MORE ON THIS TOPIC
Insights
AI Drug Discovery Platforms Face New Investor Bar
March 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Rare diseases
BioMarin Pauses Dosing, Enrollment in 2 Voxzogo Studies After Safety Signal
March 16, 2026
·
2 min read
·
Heather McKenzie
Obesity
Structure Climbs on ‘Highly Competitive’ Profile for Weight Loss Pill
March 16, 2026
·
2 min read
·
Tristan Manalac
Diabetes
Sana’s Cell Therapy Sustains Insulin Production Through 14 Months in a T1D Patient
March 16, 2026
·
2 min read
·
Tristan Manalac
